Concepedia

Mikaela Dougherty

MD

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2021

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mayo Clinic in Arizona

The University of Texas at San Antonio Health Science Center

Cleveland Clinic

Memorial Sloan Kettering Cancer Center

Mikaela Dougherty is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hematology, and myeloproliferative neoplasm treatment.

ORCID

Publications per year

2021–2023

4

Publications

4

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

Jonathan Feld, Douglas Tremblay, Mikaela Dougherty et al. · HemaSphere · 2021 · 52 citations · Full text

, , +16

PD-1 inhibition in advanced myeloproliferative neoplasms

Gabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier et al. · Blood Advances · 2021 · 42 citations · Full text

, , +15

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

John Mascarenhas, Anna Ritá Migliaccio, Heidi Kosiorek et al. · Clinical Cancer Research · 2023 · 32 citations · Full text

, , +17

Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119

Michal Bar‐Natan, John Mascarenhas, Aaron T. Gerds et al. · Blood · 2022 · 11 citations

, , +16

1–4 of 4